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　　　　　A radioimmunoassay　 for　the　measurement　 of　 17α-hydroxyprogesterone (17α-OHP) in
plasma　 was　 investigated　 utilizing　 antiserum　 produced　 by　 the　 introduction　 of　 17α-hydro-
xyproges-terone-3-oxim　 BSA.　 Accuracy　 was　 such　 that　 within-assay　 variance　 was　 16.2%
and　 between-assay　 variance　 18.3%.
　　　　　The　 17α-OHP　 mean　 plasma　 levels　 were　 930±201　 pg/ml(n=8)for　 normal　 adult　 males
and　 402±186　 pg/ml(n=11)in　 the　 follicular　 phase　 and　 1,190±662　 pg/ml(n=12)in　 the
luteal　 phase　 of　females　 with　 a　normal　 menstrual　 cycle.
　　　　　The　 17α-OHP　 levels　 in　 some　 tissues　 and　 tissue　 fluid　 also　 were　 measured,　 being
18.06±12.91 ng/ml(n=6) in　 the　 normal　 trophoblastic　 tissue,　 1.7±0.5　 ng/ml(n=17)
in　 the　 trophoblastic　 tissue　 of　a　hydatidiform　 mole　 and　 855.5±507.4　 ng/ml(n=5)in　 lutein
cyst　 fluid.
                   INTRODNCTION 
     We investigated a radioimmunoassay for the measurement of 17a-hydroxyprogesterone 
(17a-OHP) in plasma utilizing antiserum resulting from the introduction of 17a-hydroxy-
progesterone. Levels of 17a-OHP in some tissues and plasma also were measured. The 
results are reported herein.
              MATERIALS AND METHODS 
1) Specificity of the Antiserum 
    The specificity of the antiserum used was tested by cross reaction studies with various
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Table 1. Cross reactions of various steroids with 
        antiserum Produced by 17a-OHP-BSA
steroid compounds % cross reaction steroid compounds % cross reaction 
17a-hydroxy 100 corticosterone 0.04 
        progesterone 
progesterone 7.85 cortisol 0.04 
20a -hydroxy 3.23 aldosterone 0.04 
        progesterone 
11-deoxy cortisol 0.88 testosterone 0.04 
11-deoxy 0.66 dehydroepiandro- 0.04 
       corticosterone sterone 
pregnenolone 0.52 estrone 0.04 
androst-4-ene-3,17, 0.25 estradiol-17(3 0.04 
            dione 
5-P-pregnanediol 0'.08 estriol 0.04
Fig. 1 Chromatographic pattern of progesterone 
       and 17a-OHP in Sephadex LH-20 microcolumn
steroids (Table 1). The cross reaction of 17a-OHP was taken as 100%. Cross reaction 
of progrsterone and 20a-OHP-progesterone was 7.85% and 3.23%, respectively, but that 
of all other steroids in the test was less than 1 % . 
2) Plasma Extraction, Separation and Purification 
    1 x 103 dpm volume of 3H-17a-OHP was added to plasma to produce an internal 
standard for recovery estimations. Extraction of 17a-OHP was carried out with 4ml of 
ether, following which the etheral extract was transferred to other tubes and evaporated 
to dryness at 37-40°C. The dried residue was dissolved in a benzenemethanol (95 : 5 
solvent) and then chromatographic separation of 17a-OHP was accomplished by Sephadex 
LH-20 microcolumn chromatography (Fig. 1). 
3) Standard Curve 
   Titration of the antiserum revealed that a dilution of 1 : 4 x 104 was most suitable 
for assay. Namely, when the antiserum was diluted 40,000 times, the calibration curve 
became an almost straight line in the range of 0-1,000 pg of 17a-OHP (Fig. 2). In this 
range, the 17a-OHP percent bound to antiserum displayed a standard deviation of ±0. 1-
±0.7 and a coefficient of variation of 0.2-3.7%.
Fig 2 Standard curve with antiserum produced by 
     17a-OHP-BSA and diluted 1/4X 104
4) Measurement Procedure 
   The measurement procedure is as shown in Figure 3. The concentration of 17a-OHP 
in plasma was calculated by the following formula : 
     E x (M -m) x 100 x 1 where 
     R Re, Plasma sample (ml) 
     E=affluent from column chromatography 
     R=volume of effluent used in RIA 
     M=17a-OHP value estimated by 
         standard curve 
     m=value of water sample for testing blank of system 
     Re% -recovery percentage 
                              Serum 0.01^-1.0ml 
                                      added 1x lO3dpm 3H-17a-OHP 
                                        (for recovery) 
                        Extraction 
                                4 ml Ethyl Ether 
                                      twice 
                        Dry 
                                         37-V40°C 
                                       under N2 gas spray 
                       Sephadex LH-20 column chromatography
             2/3 1/3 
                   Assay Recovery
                                                  counted for 3H
                       3H-17a-OHP 1 x 104 dpm added 
                      dried by N2 gas spray at 45°C
               Incubation with diluted antiserum 
                      (0.3ml antiserum 1/4 x 104 dilution) 
                         (room temp. 30 min.) 
                Separation of "free" and "bound" forms 
                        0.3ml of dextran-coated charcoal added in ice bath. 
                        Incubated 5^-10 min. 
                       2500-3000 rpm. centrifuged for 10 min. 
                 Supernatant 0.3 ml 
                         3H counted counted
                        Calculation of concentration 
                          from calibration curve.
                              Fig. 3 Measurement procedure
5) Accuracy and Precision 
   The accuracy of the assay is shown in Table 2. The coefficient of variation varied 
between 8.3% and 17.3%. Within-assay and between-assay variances were 16.2% (n= 
17) and 18.3% (n=9), respectively.
Table 2. Accuracy of measurement 
        (Recovery of 17 -OHP added to 1 ml of distilled water)
                                   17a -OHP                  17a -OHP standard coefficient of 
              added (pg) (mean) easue(pg) deviation (±) variation (%) 
                      25 27.4 2.7 9.9 
Distilled 50 53.2 9.2 17.3 
water 100 96.2 8.0 8.3 
 lml 200 191.0 20.0 10.5 
                   500 345.2 25.5 7.0
                     RESULTS 
     The plasma 17a-OHP levels determined by the assay were 930±201 pg/ml (n=8) 
in normal adult males, and 402±186 pg/ml (n=11) in the follicular phase and 1,190±662 
pg/ml (n=12) in the luteal phase of females with a normal menstrual cycle. 
     Plasma levels of LH, estradiol, progesterone and 17a-OHP during the menstrual 
cycle of the same female were examined, the results of this being shown in Fig. 4. In 
a normal pregnancy, the plasma 17a-OHP level was observed to be 2.03±0.65 ng/ml (n 
=5) at the 7th to 17th weeks. 
     We next examined tissue levels of 17a-OHP. Normal trophoblastic tissue and the 
tissue of a hydatidiform mole were homogenized and the levels of 17a-OHP in the super-
natants determined. The levels were 18.06±12.91 ng/ml (n=6) and 1.71±0.5 ng/ml, 
respectively. Lutein cyst fluid obtained during surgery involving a destructive mole and 
chorioepithelioma also was examined and the 17a-OHP level was found to be 855.5 ±507.4 
ng/ml (n = 5).
Fig. 4 The plasma levels of LH, 17a-OHP, estradiol and progesterone simul-
       taneously measured in one person during normal menstrual cycle.
                    DISCUSSION 
     The antiserum used in the assay displayed cross reactions of 7.85% and 3.23%, 
respectively, with progesterone and 20a-hydroxyprogesterone, but its cross reactions with 
all other steroids tested were less than 1%. The specificity of our serum, when compared
with the antiserum in ABRAHAM's RIA1) and the cortisol binding globulin of competitive 
protein binding assay (CPBA) 3)4) , proved to be far better. 
     The plasma 17a-OHP level we obtained with normal males was 930±201 pg/ml (n 
=8) , a value very similar to the 950±310 pg/ml (n=18) (CPBA) obtained by STROTT5) 
and the 870±530 pg/ml (n=13) (RIA) obtained by Abraham1). However, it was rather 
lower than the value of 1,400 ± 100 pg/ml (n=10) (RIA) obtained by YOUSSENFNEJADIAN6). 
Values obtained in the follicular and luteral phase of normally menstruating females coincided 
with those obtained by other investigators 1)4)6) . 
     Normal trophoblastic tissue showed a far higher level of 17a-OHP (18.06±12.91 
ng/ml) than hydatidiform mole tissue (1.71 ±0.50 ng/ml). In addition, there have been 
reports that 17a-hydroxysteroid dehydrogenase is not found in the trophoblastic tissue of 
either destructive mole or hydatidiform moles). Based on these facts, it can be assumed 
that there is a considerably lower rate of 17a-OHP biosynthesis in molar tissue. 
     A great deal of 17a-OHP (855±507.4 ng/ml) was found to be contained in lutein 
cyst fluid obtained through surgery involving a destructive mole or chorioepithelioma. 
MIURA2), one of the authors, has previously reported that the decrease in plasma levels 
of hCG, estradiol and progesterone was found to be delayed in a patient with lutein cyst. 
It is our opinion that in the case of such patients, a large amount of the hormones 
contained in the lutein cyst is continually released into plasma, and this may be the cause 
of the delayed decrease. Therefore, the measurement of plasma 17a-OHP levels as that 
of other steroid hormones could provide useful clues to the condition of a lutein cyst.
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